Methods
Session: Poster Session C
Nicolas Praet, DVM, MSc, PhD
Senior Epidemiologist
Johnson & Johnson Innovative Medicine, Belgium
Corinne Willame, MPH, PhD
Epidemiologist
Johnson & Johnson, Belgium
Kevin Haynes, PharmD, MSCE (he/him/his)
Associate Director of Epidemiology
Johnson and Johnson Innovative Medicine
Horsham, United States
Joel N. Swerdel, PhD MS MPH (he/him/his)
Director
Johnson and Johnson Innovative Medicine
Titusville, United States
James Weaver, MS, MPH
Associate Director
Janssen R&D, United States
Eva-Maria Didden, PhD
Associate Director Epidemiology
Johnson & Johnson
Allschwil, Switzerland
Daniel Rosenberg, PhD
Cross-Therapy Area Leader, Global Epidemiology
Johnson & Johnson
Allschwil, Switzerland
emily Yost
Johnson & Johnson, United States